Company / Working Capital
Vaxcyte, Inc. Working Capital History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$1.4B
FY2025
5-year range
$227.6M / $1.6B
FY2021-FY2025
Trend
-13.7%
vs FY2024
Sector context
#31 of 213
Health Care
What the data says
Vaxcyte, Inc.'s working capital of $1.4B is higher than 85% of companies in the Health Care sector (FY2025). Working Capital has fluctuated over the past 7 years, ranging from $51M in FY2019 to $1.6B in FY2024.
Based on SEC 10-K filings.
$1.4B in FY2025 with a 5-year CAGR of +33.0%. Top quartile in the Health Care sector.
Improved from $951M to $1.4B over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +16.4%
- 5-Year CAGR
- +33.0%
- 10-Year CAGR
- -
Sector benchmark
Top 15% in Health CareTop 15% of 213This company $1.4B Sector average $934.6M
▼
+52.1% above sector average
Key checks
Key Insights
- 5-year CAGR of +33.0%, indicating consistent growth.
- In FY2025, working capital decreased 13.7% year-over-year.
- Ranks #31 out of 213 companies in the Health Care sector.
- Peak working capital was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 2.94 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.4B | -13.7% |
| FY2024 | $1.6B | +73.3% |
| FY2023 | $950.6M | +5.4% |
| FY2022 | $902.0M | +296.3% |
| FY2021 | $227.6M | -33.5% |
| FY2020 | $342.1M | +575.2% |
| FY2019 | $50.7M | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026